Klinisk och translationell melanomforskning – Hanna Erikssons forskargrupp

Publikationer

Utvalda publikationer

• Article: ANNALS OF ONCOLOGY. 2023;34(4):420-430

  Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials

  Versluis JM; Menzies AM; Sikorska K; Rozeman EA; Saw RPM; van Houdt WJ; Eriksson H; Klop WMC; Ch'ng S; van Thienen JV; Mallo H; Gonzalez M; Acosta AT; Grijpink-Ongering LG; van der Wal A; Bruining A; van de Wiel BA; Scolyer RA; Haanen JBAG; Schumacher TN; van Akkooi ACJ; Long GV; Blank CU
• Article: BRITISH JOURNAL OF DERMATOLOGY. 2023;188(1):32-40

  Association of metformin use and survival in patients with cutaneous melanoma and diabetes

  Krakowski I; Habel H; Nielsen K; Ingvar C; Andersson TML; Girnita A; Smedby KE; Eriksson H
• Article: NEOPLASIA: AN INTERNATIONAL JOURNAL FOR ONCOLOGY RESEARCH. 2021;23(8):783-791

  Plasma proteome alterations by MAPK inhibitors in BRAF^V600-mutated metastatic cutaneous melanoma

  Babacic H; Eriksson H; Pernemalm M
• Article: ANNALS OF ONCOLOGY. 2021;32(6):766-777

  Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma

  Rawson RV; Adhikari C; Bierman C; Lo SN; Shklovskaya E; Rozeman EA; Menzies AM; van Akkooi ACJ; Shannon KF; Gonzalez M; Guminski AD; Tetzlaff MT; Stretch JR; Eriksson H; van TJV; Wouters MW; Haanen JBAG; Klop WMC; Zuur CL; van Houdt WJ; Nieweg OE; Ch'ng S; Rizos H; Saw RPM; Spillane AJ; Wilmott JS; Blank CU; Long GV; van de Wiel BA; Scolyer RA
• Article: NATURE MEDICINE. 2021;27(2):256-263

  Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

  Rozeman EA; Hoefsmit EP; Reijers ILM; Saw RPM; Versluis JM; Krijgsman O; Dimitriadis P; Sikorska K; van de Wiel BA; Eriksson H; Gonzalez M; Torres Acosta A; Grijpink-Ongering LG; Shannon K; Haanen JBAG; Stretch J; Ch'ng S; Nieweg OE; Mallo HA; Adriaansz S; Kerkhoven RM; Cornelissen S; Broeks A; Klop WMC; Zuur CL; van Houdt WJ; Peeper DS; Spillane AJ; van Akkooi ACJ; Scolyer RA; Schumacher TNM; Menzies AM; Long GV; Blank CU
• Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(1):105-115

  Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting

  Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(14):1591-1601

  Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram

  Maurichi A; Miceli R; Eriksson H; Newton-Bishop J; Nsengimana J; Chan M; Hayes AJ; Heelan K; Adams D; Patuzzo R; Barretta F; Gallino G; Harwood C; Bergamaschi D; Bennett D; Lasithiotakis K; Ghiorzo P; Dalmasso B; Manganoni A; Consoli F; Mattavelli I; Barbieri C; Leva A; Cortinovis U; Espeli V; Mangas C; Quaglino P; Ribero S; Broganelli P; Pellacani G; Longo C; Del Forno C; Borgognoni L; Sestini S; Pimpinelli N; Fortunato S; Chiarugi A; Nardini P; Morittu E; Florita A; Cossa M; Valeri B; Milione M; Pruneri G; Zoras O; Anichini A; Mortarini R; Santinami M
• Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020;8(1):e000204

  In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma

  Babacic H; Lehtio J; de Coana YP; Pernemalm M; Eriksson H
• Article: FRONTIERS IN ONCOLOGY. 2020;10:51

  Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma

  Rad Pour S; Morikawa H; Kiani NA; Gomez-Cabrero D; Hayes A; Zheng X; Pernemalm M; Lehtio J; Mole DJ; Hansson J; Eriksson H; Tegner J
• Article: THE LANCET. 2019;394(10197):471-477

  2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

  Utjes D; Malmstedt J; Teras J; Drzewiecki K; Gullestad HP; Ingvar C; Eriksson H; Gillgren P
• Article: THE LANCET ONCOLOGY. 2019;20(7):948-960

  Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

  Rozeman EA; Menzies AM; van Akkooi ACJ; Adhikari C; Bierman C; van de Wiel BA; Scolyer RA; Krijgsman O; Sikorska K; Eriksson H; Broeks A; van Thienen JV; Guminski AD; Acosta AT; ter Meulen S; Koenen AM; Bosch LJW; Shannon K; Pronk LM; Gonzalez M; Ch'ng S; Grijpink-Ongering LG; Stretch J; Heijmink S; van Tinteren H; Haanen JBAG; Nieweg OE; Klop WMC; Zuur CL; Saw RPM; van Houdt WJ; Peeper DS; Spillane AJ; Hansson J; Schumacher TN; Long GV; Blank CU
• Article: CANCER RESEARCH. 2018;78(20):5970-5979

  Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma

  Thrane K; Eriksson H; Maaskola J; Hansson J; Lundeberg J
• Article: INTERNATIONAL JOURNAL OF CANCER. 2017;141(11):2243-2252

  Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study

  Utjes D; Lyth J; Lapins J; Eriksson H
• Article: JAMA DERMATOLOGY. 2015;151(4):410-416

  BRAF^V600E Protein Expression in Primary Cutaneous Malignant Melanomas and Paired Metastases

  Eriksson H; Zebary A; Vassilaki I; Omholt K; Ghaderi M; Hansson J
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(13):1356-1364

  Later Stage at Diagnosis and Worse Survival in Cutaneous Malignant Melanoma Among Men Living Alone: A Nationwide Population-Based Study From Sweden

  Eriksson H; Lyth J; Mansson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J

Medarbetare och kontakt

Gruppledare

• 

  Hanna Eriksson

  Anknuten till Forskning | Docent

  E-postadress hanna.eriksson.4@ki.se

Alla medarbetare i gruppen

• 

  Silvia Angori

  Postdoktorala Studier

  E-postadress silvia.angori@ki.se
• 

  Hanna Eriksson

  Anknuten till Forskning | Docent

  E-postadress hanna.eriksson.4@ki.se
• Johan Franzén

  Doktorand

  E-postadress johan.franzen@ki.se
• Isabelle Krakowski

  E-postadress isabelle.krakowski@ki.se
• 

  Alessandra Muni

  Doktorand

  E-postadress alessandra.muni@ki.se
• 

  Nidhi Sharma

  Postdoktorala Studier

  E-postadress nidhi.sharma@ki.se
• Sofi Vikström

  Doktorand

  E-postadress sofi.vikstrom@ki.se